Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer
Phase 3
Active, not recruiting
- Conditions
- Prostate CancerProstate AdenocarcinomaBiochemical Recurrence of Malignant Neoplasm of Prostate
- Interventions
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Curium US LLC
- Target Recruit Count
- 235
- Registration Number
- NCT06235099
- Locations
- ๐บ๐ธ
Providence Medical Foundation, Fullerton, California, United States
๐บ๐ธTower Urology, Los Angeles, California, United States
๐บ๐ธVA Greater Los Angeles Healthcare System, Los Angeles, California, United States
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
Phase 3
Recruiting
- Conditions
- Prostate AdenocarcinomaProstate Cancer
- Interventions
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Curium US LLC
- Target Recruit Count
- 323
- Registration Number
- NCT06235151
- Locations
- ๐บ๐ธ
Arkansas Urology, Little Rock, Arkansas, United States
๐บ๐ธProvidence Medical Foundation, Fullerton, California, United States
๐บ๐ธTower Urology, Los Angeles, California, United States
Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer
Phase 2
Completed
- Conditions
- Metastasis From Malignant Tumor of Prostate (Disorder)
- Interventions
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Curium US LLC
- Target Recruit Count
- 26
- Registration Number
- NCT05653856
- Locations
- ๐บ๐ธ
Yale University, New Haven, Connecticut, United States
๐บ๐ธEdward Hines, Jr. VA Hospital, Hines, Illinois, United States
๐บ๐ธJohns Hopkins University, Baltimore, Maryland, United States
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
Phase 3
Active, not recruiting
- Conditions
- Metastasis From Malignant Tumor of Prostate
- Interventions
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Curium US LLC
- Target Recruit Count
- 439
- Registration Number
- NCT05204927
- Locations
- ๐บ๐ธ
Arizona Institute of Urology, PPLC, Tucson, Arizona, United States
๐บ๐ธProvidence Medical Foundation, Fullerton, California, United States
๐บ๐ธLong Beach Memorial Center, Long Beach, California, United States
Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs)
- Conditions
- Neuroendocrine Tumors
- First Posted Date
- 2020-04-06
- Last Posted Date
- 2020-10-09
- Lead Sponsor
- Curium US LLC
- Registration Number
- NCT04334837